CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

STAT News
Original article

STAT+: Biotech raises $42 million to run Huntington’s disease trial

Positive
AI Analysis

Summary

Latus Bio raised $42 million to fund a clinical trial for its gene therapy targeting Huntington's disease and prepare for FDA approval to initiate the study.

Clinical Trial Data

Importance:5/10
Sentiment:
0.60
gene therapyHuntington's diseasecapital raiseclinical trialFDA approval

Read the original article

Published by STAT News on May 4, 2026 11:00 AM

Read Original